PH-5 (Trino Therapeutics)

N/A

Report date: 2025/01/26 15:10:00
NME

Base Information

Drug NamePH-5 (Trino Therapeutics)
Drug Alias NamePH-5 (Pharmatrin)PH-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMast cell degranulation inhibitors
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesLung DiseasesInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTrino Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesTrino Therapeutics
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLung DiseasesInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A